Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Otsuka Holdings Co ( (JP:4578) ) is now available.
Otsuka Pharmaceutical, a 100% subsidiary of Otsuka Holdings, has agreed to acquire all outstanding shares of U.S.-based Transcend Therapeutics via its North American holding company Otsuka America, Inc., with closing targeted for the second quarter of fiscal 2026, pending customary conditions. The deal, executed through a merger structure with cash consideration to existing Transcend shareholders, will bring into Otsuka’s portfolio TSND 201, a novel investigational psychiatric asset with a distinct mechanism of action.
The acquisition builds on Otsuka’s multi-decade strategy in psychiatric and neurological care and follows its purchase of Mindset Pharma, adding further depth in next-generation treatments targeting conditions with limited options such as PTSD. By integrating Transcend’s R&D capabilities and pipeline, Otsuka aims to strengthen its position as a global leader in mental health therapeutics, accelerate development of innovative therapies in the U.S. market, and expand future treatment choices in areas of high unmet medical need.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen13200.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., through its core subsidiary Otsuka Pharmaceutical Co., Ltd., is a Japan-based healthcare group focused on research, development, manufacture and sale of pharmaceuticals, medical devices, clinical testing equipment, and nutraceutical products. The company has a longstanding strategic emphasis on psychiatric and neurological disorders, including schizophrenia, bipolar disorder, depression and PTSD, and has been expanding its global footprint and innovation pipeline via partnerships, U.S. operations and targeted acquisitions.
Average Trading Volume: 1,275,873
Technical Sentiment Signal: Buy
Current Market Cap: Yen5850.6B
For an in-depth examination of 4578 stock, go to TipRanks’ Overview page.